Lv5
1290 积分 2023-10-09 加入
Improved cost‐effectiveness by pharmacokinetic dosing of factor VIII in prophylactic treatment of haemophilia A
1天前
待确认
Perioperative pharmacokinetic-guided factor VIII concentrate dosing in haemophilia (OPTI-CLOT trial): an open-label, multicentre, randomised, controlled trial
1天前
已完结
[Individualized prophylaxis for hemophilia children based on pharmacokinetics application]
1天前
待确认
Impact of an Individualized Prophylaxis Approach on Young Adults with Severe Hemophilia
1天前
已完结
Improvement in pain-related quality of life in patients with hemophilia A treated with rFVIIIFc individualized prophylaxis: post hoc analysis from the A-LONG study
1天前
已完结
Inter-individual variability in pharmacokinetics and clinical features in pediatric patients with severe hemophilia A
1天前
已完结
Predicting Individual Changes in Terminal Half-Life After Switching to Extended Half-Life Concentrates in Patients With Severe Hemophilia
1天前
已完结
A repeated time-to-event model for personalized treatment of patients with hemophilia A based on individual bleeding risk
1天前
待确认
The impact of individualized prophylactic treatment based on pharmacokinetic parameters on the prognosis of patients with severe hemophilia A
1天前
已完结
皖公网安备34019202002308
